Today's Small Cap Stocks Pulse
Deep Fission targets up to $1.66B valuation in fresh Nasdaq IPO
Deep Fission announced a Nasdaq IPO seeking $157M at $24‑$26 per share, which would value the company at as much as $1.66B. The filing shows its cash deficit widened to $88.1M in March from $56.2M in December.
Vanda Pharmaceuticals Inc (VNDA) Q1 2026 Earnings Call Transcript
Vanda Pharmaceuticals reported Q1 2026 net product sales of $51.7 million, a modest 3% year‑over‑year increase driven primarily by a 26% surge in Fanapt revenue and a 32% rise in prescriptions. Hetlioz sales continued to decline, falling 24% YoY amid generic competition, while Ponvory grew 10% YoY. The company raised its full‑year 2026 revenue outlook to $240‑$290 million, highlighting contributions from the newly launched Nirius and the FDA approval of Dysanti for bipolar I disorder and schizophrenia. Management warned that cash burn may exceed 2025 levels and that Nirius sales forecasts remain uncertain.
Rxsight Inc (RXST) Q1 2026 Earnings Call Transcript
RxSight reported fourth‑quarter 2025 sales of $32.6 million, a 19% year‑over‑year decline driven by sharply lower Light Delivery Device placements. The Light Adjustable Lens now represents 86% of revenue, lifting gross margin to a record‑high 77.5%. Despite a full‑year revenue increase...
Bridger Aerospace Group Holdings Inc (BAER) Q1 2026 Earnings Call Transcript
Bridger Aerospace Group Holdings (BAER) posted a full‑year revenue of $122.8 million, a 25% increase, and returned to profitability with $4.1 million net income after a loss the prior year. Adjusted EBITDA rose to $45.3 million, reflecting stronger margins on its Super Scooper...
BGSF Inc (BGSF) Q1 2026 Earnings Call Transcript
BG Staffing (BGSF) reported Q1 2026 results showing a 9.4% revenue decline to $22 million, but an improved adjusted EBITDA loss of $947 k versus $1.6 million a year earlier. The company completed the sale of its professional division, retired all debt and...
Madrigal Pharmaceuticals Inc (MDGL) Q1 2026 Earnings Call Transcript
Madrigal Pharmaceuticals reported its Q1 2026 earnings, highlighting that Rezdiffra generated $958 million in net sales for its first full year, nearly $1 billion in total revenue. Patient enrollment rose to 36,250, reflecting strong sequential growth in the expanding MASH market. The...
Quanterix Corp (QTRX) Q1 2026 Earnings Call Transcript
Quanterix Corp reported fourth‑quarter revenue of $43.9 million, a 25% year‑over‑year increase and 7% sequential growth, though organic revenue fell 22% as both Simoa and Spatial platforms declined over 20%. The company highlighted a $897 CMS reimbursement rate for its Lucent...
Sturm Ruger & Company Inc (RGR) Q1 2026 Earnings Call Transcript
Sturm Ruger reported Q4 2025 results on its March 3 2026 earnings call, showing a modest 3.6% rise in quarterly net sales to $151 million and a 1.9% increase for the full year to $546 million. Adjusted earnings came in at $0.84 per share after...
Gladstone Capital Corp (GLAD) Q2 2026 Earnings Call Transcript
Gladstone Capital Corp reported a 14% jump in interest income to $23.8 million and net originations of $103.1 million in Q2, driving a $63 million fair‑value increase in its investment portfolio. The firm completed a $149 million convertible note refinancing, reducing net debt to...
Agilon Health Inc (AGL) Q1 2026 Earnings Call Transcript
Agilon Health reported Q1 2026 revenue of $1.42 billion, down from a year earlier, as Medicare Advantage and ACO REACH memberships slipped to 426,000 and 110,000 respectively. Despite the headcount decline, medical margin rose to $149 million and adjusted EBITDA more than doubled...
Trinity Capital Inc (TRIN) Q1 2026 Earnings Call Transcript
Trinity Capital reported a record $40 million net investment income for Q4, a 15% year‑over‑year increase, and total investment income of $83 million, up 17.5%. Platform assets under management rose 38% to $2.8 billion, while net asset value hit $1.1 billion, a...
Holley Inc (HLLY) Q1 2026 Earnings Call Transcript
Holley Inc. posted Q4 2025 net sales of $155.4 million, a 10.9% year‑over‑year increase, and delivered full‑year revenue of $613.5 million—the first annual growth since 2021. Gross margin rose to 46.8% and adjusted EBITDA reached $33.2 million with a 21.4% margin, reflecting pricing...
J&J Snack Foods Corp (JJSF) Q2 2026 Earnings Call Transcript
J&J Snack Foods reported adjusted EBITDA of $28.7 million, up 9.5% YoY, and adjusted EPS of $0.40, up 14.3%, while net sales slipped 3.2% to $344.8 million. Margin expansion stemmed from the Apollo transformation, plant consolidations and a favorable sales mix, lifting...
Hagerty Inc (HGTY) Q1 2026 Earnings Call Transcript
Hagerty Inc. reported Q1 2026 results with total revenue of $357 million, up 19% year‑over‑year, driven by a 19% rise in written premiums and an 80% jump in Marketplace revenue. Net income surged 238% to $29 million and adjusted EBITDA nearly doubled...
Energy Recovery Inc (ERII) Q1 2026 Earnings Call Transcript
Energy Recovery Inc. (ERII) withdrew its 2026 financial guidance after the Iran conflict heightened risk to its Middle‑East desalination portfolio, prompting project delays into 2027. The company launched its next‑generation PX Q650 in March, securing the first commercial order and...
Vernal Capital Acquisition Corp. (VECA.U) Prices $100M IPO
Vernal Capital Acquisition Corp. (VECA.U) priced a $100 million IPO and will begin trading on the NYSE on May 6, 2026. The SPAC, led by CEO Du Jun and CFO Yi Binghan, plans a generalist search for private companies in Asia with strong economics. The...
Acusensus Reaffirms FY26 Guidance on Strong International Operational Progress
Acusensus reaffirmed its FY26 revenue guidance of $83‑87 million and adjusted EBITDA of $7.2‑8.2 million, citing a record‑size US pipeline and expanding contracts in the UK, Australia and New Zealand. The company posted a 40% revenue jump to $40.3 million in the first half...
EZGO Spikes 60x Volume, Primed for Breakout
Nearly 60x relative volume here on $EZGO today, making it a top watch for continuation tomorrow. Larger float than I typically like to play, but this chart is super clean for a textbook S/D flip setup as shown below. Plenty of range...
Overlooked Small‑Cap REIT $PINE Offers Compelling Opportunity
The REIT market as a whole has struggled under the high interest rate environment over the last couple of years- But that has led to some REITs becoming quite interesting opportunities. I believe $PINE is one of those REITs, but also a...
MiniMed IPO Points to Smarter Diabetes Devices
Medtronic spun off its diabetes technology unit MiniMed in a March IPO, offering 28 million shares at $20 each and raising roughly $538 million. Post‑offering Medtronic retains about 90 % of MiniMed’s common stock, preserving strategic control. Shortly after the listing, MiniMed secured...
Nebius Earnings Depend on Q1 Operating Cash Flow
Nebius’ next earnings could hinge on one key number: Operating Cash Flow. Strong OCF = self-funded growth. Weak OCF = possible dilution. All eyes on Q1. 📉 NBIS
GPK Reaffirms Guidance Amid $400M Buyback, Waco Ramp‑Up
GPK just dropped their Q1 2026 update. Despite a choppy demand environment, they bought back $400M in stock YTD and reaffirmed guidance. Waco is ramping up, and they’re managing tariff uncertainty. Solid execution. 📦💪 PackagingNews
Pexip Holding ASA Posts Q1 Profit Surge, Revenue Up 30%
Pexip Holding ASA announced a first‑quarter profit of $13.10 million, more than double the $5.92 million earned a year earlier. Revenue climbed 29.7% to $40.75 million, underscoring robust demand for its collaboration platform across Europe. The results reinforce the broader Nordic tech rally...
Small Caps Put on Their Best Monthly Showing Since 2020. Bank of America Says There's More Upside Ahead
Small‑cap stocks surged in April, with the Russell 2000 posting a 12% gain—the strongest monthly rise since November 2020 and outpacing the S&P 500’s 10.4% increase. Bank of America analysts attribute the rally to an earnings‑per‑share and manufacturing recovery and expect further upside....
Book Value Stability Affirms Ellington Financial Inc. (EFC) as a Top Undervalued REIT Stock to Buy
Ellington Financial Inc. (EFC) received a Market Outperform rating from Citizens on April 2, with a $14 price target that translates to 1.04 times its reported book value per share. The firm’s book value stands at $13.56, bolstered by a $0.13 monthly...
Ero Copper Posts $108.8 M Q1 Profit as Copper Demand Surges
Ero Copper Corp announced first‑quarter 2026 net income of $108.8 million, a 36% jump from a year earlier, while revenue more than doubled to $263.2 million. The results reflect record copper output, higher gold concentrate sales and aggressive debt reduction as the...
Secunet Security Networks Q1 2026
Secunet Security Networks posted a record Q1 2026 order intake, outpacing the prior year by roughly 27 %. The surge pushed its order backlog to an 18‑month runway, enough to keep factories busy through 2027. New contracts with NATO’s cyber‑defense unit and...
Divergent Analyst Targets Signal Brutal Post‑earnings IV Crush
$ALAB reports in couple hours RBC: $250 target UBS: $180 target That's a 39% spread... on the same stock... from the same data When analysts can't agree the IV crush after earnings is brutal
Telesat Confirms Fully Funded 2028 Lightspeed Timeline Following Q1 Design Reviews
Telesat reported Q1 2026 results, investing roughly $125 million USD in its Lightspeed LEO constellation, bringing total spend to about $2 billion USD. The company confirmed it is fully funded to launch global commercial service by the first quarter of 2028. A $800 million...
Keep Buying Five Below as It Leans Into Squishy Dumplings, Says Analyst
Wolfe Research upgraded Five Below (FIVE) to an outperform rating, lifting its price target to $291, implying about 26% upside. The analyst highlighted the surge in "squish" toys—especially the viral dumpling items—as a key, under‑appreciated growth driver. TikTok‑fueled demand for...
SoFi's Upside Could Range From 35% To
$SOFI Street Targets: Low: $16 Consensus: $22, 35% Upside High: $38, 138% Upside Who is right?
New SPAC: Keystone Acquisition Corp. (KEYYU) Files for $250M IPO
Keystone Acquisition Corp., ticker KEYYU, has filed an S‑1 to launch a $250 million special purpose acquisition company (SPAC) IPO. The offering targets a cash pool that will be used for future acquisitions in technology or industrial sectors. The board includes...
Laureate Education Posts $236 M Q1 2025 Revenue, Highlights Seasonal Slowdown
Laureate Education posted $236 million in first‑quarter 2025 revenue, a seasonally low figure, while reporting 10% organic constant‑currency growth and a 7% rise in new enrollments. Management flagged an $8 million one‑time revenue loss in Mexico and warned of near‑term volatility from...
Elmos Semiconductor Boosts FY26 Outlook After 41% Q1 Profit Surge
Elmos Semiconductor SE lifted its fiscal‑2026 guidance after reporting a 41.2% jump in Q1 net income to €26.2 million and a 20.2% rise in sales to €152.5 million. The German firm said accelerating demand for automotive semiconductors and a “significant growth opportunity”...
L.B. Foster Q1 Sales Jump 23.9% as Rail Segment Fuels Profit Surge
L.B. Foster posted a 23.9% rise in net sales to $121.1 million for the first quarter of 2026, led by a 38.4% jump in rail segment revenue. The company also saw EBITDA climb 183% to $5.2 million while cutting net debt by...
Paymentus Posts 30% Revenue Surge, Raises Full-Year Outlook to $1.44 B
Paymentus Holdings (PAY) announced Q1 2026 revenue of $358.4 million, up 30.2% year over year, and lifted its full‑year revenue guidance to $1.425‑$1.44 billion. The growth was driven by new enterprise billers, a surge in transaction volume and the rollout of its...
$STVN: Are Oral GLP-1s Really a Death Blow? | Aurelion Research's Leo Trudel
Stevanato Group (STVN), a leading supplier of glass vials and pre‑filled syringes for GLP‑1 therapies, saw its shares slide amid speculation that oral GLP‑1 formulations could erode demand for injectable delivery. Analyst Leo Trudel argues this view overlooks continued growth...
Twist Bioscience Q2 2026 Loss Widens as Synthetic DNA Demand Slows
Twist Bioscience Corp posted a second‑quarter 2026 net loss of $44.0 million, or $0.71 per share, compared with a $39.3 million loss a year ago. Revenue rose 19.3% to $110.7 million, but the widening loss highlights pressure on the synthetic‑DNA market as demand...
Viper Energy Adds $8 B in Mineral Assets, Triples Permian Acreage in Q4 2025
Viper Energy disclosed more than $8 billion of mineral acquisitions during its Q4 2025 earnings call, expanding Permian Basin acreage nearly 2.5‑times. The deal coincided with a 15% dividend hike, a $1 billion boost to share‑repurchase authority and a reduction of net...
HealthStream Posts 1% Q1 2025 Revenue Rise, Leans on SaaS Growth Amid Legacy Decline
HealthStream (HSTM) posted Q1 2025 revenue of $73.5 million, a 1% rise year‑over‑year, thanks to strong SaaS bookings and a $14 million five‑year contract. Legacy credentialing and scheduling losses and a customer bankruptcy weighed on operating income, which fell 23% to $4.4 million.
ThredUp Q1 Revenue Jumps 14.6% to $81.7 M on Record Buyer Gains
ThredUp posted first‑quarter 2026 revenue of $81.7 million, up 14.6% year over year, as new‑buyer acquisition and marketing efficiencies lifted active buyers 25% and orders 19.3%. The growth came with a slight dip in average selling price and a 190‑basis‑point decline...
Qualstar Corporation Reports First Quarter 2026 Results
Qualstar Corporation posted Q1 2026 results showing a 14% revenue decline to $1.43 million, driven by weaker power‑supply sales but offset by higher tape‑storage product demand. Gross margin slipped to 26% from 36.7% as the product mix shifted toward lower‑margin items. The...
Permian Land Firm EagleRock Launches IPO Targeting up to $400 Million
EagleRock Land has filed for an initial public offering that could raise up to $398 million by selling 17.3 million shares priced between $17 and $20. The proceeds would fund the company’s extensive surface acreage and infrastructure in the heart of the...
Disc Medicine Reports First Quarter 2026 Financial Results and Provides Business Update
Disc Medicine reported Q1 2026 results, highlighting the completion of enrollment in its Phase 3 APOLLO trial of bitopertin for erythropoietic protoporphyria, with topline data expected in Q4 2026. The company also announced that Phase 2 data for DISC‑0974 in myelofibrosis‑related anemia will be...
An Attractive Entry Point Has Emerged in This Name Tied to AI Data Centers, Says JPMorgan
JPMorgan upgraded Cogent Communications to Overweight after a 29% plunge, setting a $22 price target that implies roughly 34% upside. The bank highlighted a 9% year‑over‑year rise in On‑Net and Waves revenue and progress on selling ten data centers, which...
Small‑cap Growth Outperforms Large‑cap, yet Remains Ignored
Wow, 100% of small cap growth funds are beating large cap growth over the past year. This number is 10% for five years = small cap is having a legit moment rn. $IWM also just hit ATHs. And yet, no...
Microcaps Surge 21% While Mid‑Caps Lag Behind
$IWC microcaps leading off the March 30 low... +21% $SPY +14.5% Profitable mid-caps lagging +11.5% @stockcharts https://t.co/lRb6cd508o
NBIX Surges on Earnings, Gains 12 Points
$NBIX booming on earnings, want to keep this position but up a quick 12 pts https://t.co/pFPVwIuDXX
Doby George Gold Deposit Nears Permit, Still Undervalued
As JV puts it, @WEXExploration's Doby George #gold deposit "puts on its work boots." Management preparing to submit the Mine Plan of Operations permit, while continuing to de-risk it for a future construction decision. Stock is cheap-cheap, I'm overweight: https://t.co/9uiPsVlHSb
Lithium Corp's 1,000% Surge May Return Amid Lithium Rally
Lithium Corp $LTUM. Spec lithium play that rose 1,000% in October not long after I profiled it. Will lightning strike again? Li prices on a powerful run. Exposure to Li, Neodymium, Graphite and Fluorspar. https://t.co/5n3anYQ83F
UMB Financial Reaffirms M&A Plans; Blue Owl Declines Offer
In Play Today: UMB Financial $UMBF reiterates future M&A requirements; Blue Owl rejects buyout offer | S&P Global Market Intelligence https://t.co/qDTqHhJTSr